Page last updated: 2024-10-28

haloperidol and B-Cell Chronic Lymphocytic Leukemia

haloperidol has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walter, RB1
Hoofnagle, AN1
Lanum, SA1
Collins, SJ1

Other Studies

1 other study available for haloperidol and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Acute, life-threatening hypoglycemia associated with haloperidol in a hematopoietic stem cell transplant recipient.
    Bone marrow transplantation, 2006, Volume: 37, Issue:1

    Topics: Anti-Infective Agents; Glucose; Hallucinations; Haloperidol; Hematopoietic Stem Cell Transplantation

2006